These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
304 related items for PubMed ID: 17216624
1. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Källén BA, Otterblad Olausson P. Birth Defects Res A Clin Mol Teratol; 2007 Apr; 79(4):301-8. PubMed ID: 17216624 [Abstract] [Full Text] [Related]
2. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. Bérard A, Zhao JP, Sheehy O. BMJ Open; 2017 Jan 12; 7(1):e013372. PubMed ID: 28082367 [Abstract] [Full Text] [Related]
4. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. Gao SY, Wu QJ, Sun C, Zhang TN, Shen ZQ, Liu CX, Gong TT, Xu X, Ji C, Huang DH, Chang Q, Zhao YH. BMC Med; 2018 Nov 12; 16(1):205. PubMed ID: 30415641 [Abstract] [Full Text] [Related]
5. Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study. Wemakor A, Casson K, Garne E, Bakker M, Addor MC, Arriola L, Gatt M, Khoshnood B, Klungsoyr K, Nelen V, O'Mahoney M, Pierini A, Rissmann A, Tucker D, Boyle B, de Jong-van den Berg L, Dolk H. Eur J Epidemiol; 2015 Nov 12; 30(11):1187-98. PubMed ID: 26148560 [Abstract] [Full Text] [Related]
6. SSRI antidepressants and birth defects. Prescrire Int; 2006 Dec 12; 15(86):222-3. PubMed ID: 17167929 [Abstract] [Full Text] [Related]
8. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. Louik C, Lin AE, Werler MM, Hernández-Díaz S, Mitchell AA. N Engl J Med; 2007 Jun 28; 356(26):2675-83. PubMed ID: 17596601 [Abstract] [Full Text] [Related]
14. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM, National Birth Defects Prevention Study. N Engl J Med; 2007 Jun 28; 356(26):2684-92. PubMed ID: 17596602 [Abstract] [Full Text] [Related]
15. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D. Birth Defects Res B Dev Reprod Toxicol; 2007 Feb 28; 80(1):18-27. PubMed ID: 17187388 [Abstract] [Full Text] [Related]
16. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Reis M, Källén B. Psychol Med; 2010 Oct 28; 40(10):1723-33. PubMed ID: 20047705 [Abstract] [Full Text] [Related]
17. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Wogelius P, Nørgaard M, Gislum M, Pedersen L, Munk E, Mortensen PB, Lipworth L, Sørensen HT. Epidemiology; 2006 Nov 28; 17(6):701-4. PubMed ID: 17028507 [Abstract] [Full Text] [Related]
18. Antidepressant use in pregnancy and the risk of cardiac defects. Huybrechts KF, Palmsten K, Avorn J, Cohen LS, Holmes LB, Franklin JM, Mogun H, Levin R, Kowal M, Setoguchi S, Hernández-Díaz S. N Engl J Med; 2014 Jun 19; 370(25):2397-407. PubMed ID: 24941178 [Abstract] [Full Text] [Related]